Cargando…
Clinical benefits of inhaled ciclesonide for hospitalized patients with COVID-19 infection: a retrospective study
BACKGROUND: The successful management of patients infected with coronavirus disease 2019 (COVID-19) with inhaled ciclesonide has been reported, however few studies have investigated its application among hospitalized patients. METHODS: This retrospective cohort study enrolled all adult patients admi...
Autores principales: | Kuo, Kuan-Chih, Chen, Chao-Hsien, Wang, Chieh-Jen, Wu, Jou-Chun, Chung, Hsin-Pei, Chen, Yen-Ting, Tang, Yen-Hsiang, Chang, Wen-Kuei, Lin, Chang-Yi, Wu, Chien-Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9517967/ https://www.ncbi.nlm.nih.gov/pubmed/36171597 http://dx.doi.org/10.1186/s12890-022-02168-8 |
Ejemplares similares
-
Inhaled ciclesonide for outpatients with COVID-19: A meta-analysis
por: Hsu, Chi-Kuei, et al.
Publicado: (2022) -
Outcome prediction in hospitalized COVID-19 patients: Comparison of the performance of five severity scores
por: Chung, Hsin-Pei, et al.
Publicado: (2023) -
Is there a role for inhaled ciclesonide in the treatment of COVID-19?
por: Salvi, Sundeep Santosh
Publicado: (2021) -
From inhaler to lung: clinical implications of the formulations of ciclesonide and other inhaled corticosteroids
por: Nave, Ruediger, et al.
Publicado: (2013) -
Ciclesonide: a safe and effective inhaled corticosteroid for the treatment of asthma
por: Schaffner, Timothy J, et al.
Publicado: (2009)